Whalerock Point Partners’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-220,800
Closed -$2.05M 154
2016
Q4
$2.05M Buy
220,800
+22,425
+11% +$232K 0.81% 30
2016
Q3
$2.1M Buy
+198,375
New +$1.98M 0.87% 27
2016
Q1
$2.04M Buy
196,675
+37,350
+23% +$341K 0.88% 25
2015
Q4
$1.6M Buy
159,325
+74,825
+89% +$750K 0.7% 31
2015
Q3
$710K Buy
84,500
+3,200
+4% +$42.4K 0.31% 63
2015
Q2
$1.31M Buy
81,300
+800
+1% +$12.4K 0.54% 38
2015
Q1
$1.14M Buy
80,500
+22,000
+38% +$286K 0.46% 41
2014
Q4
$584K Sell
58,500
-19,300
-25% -$165K 0.25% 72
2014
Q3
$662K Buy
77,800
+2,000
+3% +$17.6K 0.3% 63
2014
Q2
$670K Buy
75,800
+2,950
+4% +$25.8K 0.32% 60
2014
Q1
$678K Buy
+72,850
New +$639K 0.35% 52

Other funds holding OPK

Whalerock Point Partners's OPK Position: Q1 2017 in Review

Whalerock Point Partners sold out of Opko Health (OPK) in Q1 2017, closing a stake of 220,800 shares — an estimated $2.05M sold.

Whalerock Point Partners first reported a position in OPK in Q1 2014 and held it in 11 quarters. The position peaked at $2.1M in Q3 2016. 245 funds tracked by Wall St. Rank hold OPK as of Q1 2017.

  • Whalerock Point Partners reported no remaining Opko Health position as of Q1 2017 after selling out during the quarter.
  • Whalerock Point Partners sold 220,800 Opko Health shares in Q1 2017, an estimated $2.05M.
  • Whalerock Point Partners first reported a position in Opko Health in Q1 2014 and held it in 11 quarters.
  • Whalerock Point Partners's Opko Health position peaked at $2.1M in Q3 2016.
  • 245 funds tracked by Wall St. Rank held Opko Health as of Q1 2017.

Based on Whalerock Point Partners's 13F filing for Q1 2017, filed 19 Apr 2017.